Valeant Pharmaceuticals International Inc (VRX): Today's Featured Health Care Loser
Valeant Pharmaceuticals International Inc
(
) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 1.8%. By the end of trading, Valeant Pharmaceuticals International Inc fell $1.47 (-3.6%) to $39.56 on light volume. Throughout the day, two million shares of Valeant Pharmaceuticals International Inc exchanged hands as compared to its average daily volume of 3.4 million shares. The stock ranged in price between $39.55-$40.61 after having opened the day at $40.23 as compared to the previous trading day's close of $41.03. Other company's within the Health Care sector that declined today were:
(
), down 33.4%,
Integra LifeSciences Holdings Inc
(
), down 16.4%,
(
), down 11.7%, and
BioSpecifics Technologies Corporation
(
), down 10.9%.
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products. Valeant Pharmaceuticals International Inc has a market cap of $11.6 billion and is part of the
industry. Shares are up 44.2% year to date as of the close of trading on Friday.
TheStreet Ratings rates Valeant Pharmaceuticals International as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and disappointing return on equity.
- You can view the full Valeant Pharmaceuticals International Ratings Report.
On the positive front,
(
), up 20.9%,
(
), up 16.7%,
(
), up 15.8%, and
(
), up 14%, were all gainers within the health care sector with
(
) being today's featured health care sector winner.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null
